Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HER2Bi-armed Activated T Cells in HER2-negative Metastatic Breast Cancer
NCT01022138Phase 2Terminated
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Start
- Mar 2010
- Primary completion
- Nov 2015
- Countries
- 1
01
Overview
A Phase 2 trial of HER2Bi-armed activated T cells in breast cancer, sponsored by Barbara Ann Karmanos Cancer Institute. Started Mar 2010; status: terminated.
02
Drugs
HER2Bi-armed activated T cells
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01022138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01022138.